Skip to main content
Top
Published in: Journal of Bioethical Inquiry 2/2009

01-06-2009

Increasing Knowledge of HIV Infection Status through Opt-Out Testing

Opt-Out HIV Testing

Author: Harold W. Jaffe

Published in: Journal of Bioethical Inquiry | Issue 2/2009

Login to get access

Abstract

The diagnosis of HIV infection is the point of entry for treatment and prevention services, yet many infected persons in both developed and developing countries remain undiagnosed. To reduce the number of undiagnosed infections, a variety of expanded testing policies have been recommended, including opt-out testing. This testing model assumes that in populations of increased HIV prevalence, voluntary testing should be offered to all patients seen in healthcare settings and performed unless patients specifically decline. While this approach raises ethical issues concerning “voluntariness”, access to care, and stigma, the potential benefits of opt-out testing far outweigh its potential adverse effects.
Literature
go back to reference Bhaskaran, K., O. Hamouda, S. Sannes, F. Boufassa, A.M. Johnson, P.C. Lambert, et al. 2008. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. Journal of the American Medical Association 300: 51–59. doi:10.1001/jama.300.1.51.PubMedCrossRef Bhaskaran, K., O. Hamouda, S. Sannes, F. Boufassa, A.M. Johnson, P.C. Lambert, et al. 2008. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. Journal of the American Medical Association 300: 51–59. doi:10.​1001/​jama.​300.​1.​51.PubMedCrossRef
go back to reference Centers for Disease Control. 1985. Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 34: 75–78. Centers for Disease Control. 1985. Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 34: 75–78.
go back to reference Centers for Disease Control and Prevention. 2001a. Revised recommendations for HIV screening of pregnant women. MMWR. Recommendations and Reports, 50(RR19): 59–86. Centers for Disease Control and Prevention. 2001a. Revised recommendations for HIV screening of pregnant women. MMWR. Recommendations and Reports, 50(RR19): 59–86.
go back to reference Centers for Disease Control and Prevention. 2001b. Revised guidelines for HIV counseling, testing, and referral. MMWR Recommendations and Reports 50 (RR19): 1–58. Centers for Disease Control and Prevention. 2001b. Revised guidelines for HIV counseling, testing, and referral. MMWR Recommendations and Reports 50 (RR19): 1–58.
go back to reference Centers for Disease Control and Prevention. 2003. Advancing HIV prevention: New strategies for a changing epidemic—United States, 2003. Morbidity and Mortality Weekly Report 52: 329–332. Centers for Disease Control and Prevention. 2003. Advancing HIV prevention: New strategies for a changing epidemic—United States, 2003. Morbidity and Mortality Weekly Report 52: 329–332.
go back to reference Centers for Disease Control and Prevention. 2006. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and Reports, 55(RR14): 1–17. Centers for Disease Control and Prevention. 2006. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and Reports, 55(RR14): 1–17.
go back to reference Collaborative Group on AIDS Incubation and HIV Survival. 2000. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative re-analysis. Lancet 355: 1131–1137. doi:10.1016/S0140-6736(00)02061-4.CrossRef Collaborative Group on AIDS Incubation and HIV Survival. 2000. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative re-analysis. Lancet 355: 1131–1137. doi:10.​1016/​S0140-6736(00)02061-4.CrossRef
go back to reference Connor, E.M., R.S. Sperling, R. Gelber, P. Kiselev, G. Scott, M.J. O’Sullivan, et al. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. The New England Journal of Medicine 331: 1181–1187. doi:10.1056/NEJM199411033311801.PubMedCrossRef Connor, E.M., R.S. Sperling, R. Gelber, P. Kiselev, G. Scott, M.J. O’Sullivan, et al. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. The New England Journal of Medicine 331: 1181–1187. doi:10.​1056/​NEJM199411033311​801.PubMedCrossRef
go back to reference Granich, R.M., C.F. Gilks, C. Dye, K.M. DeCock, and B.G. Williams. 2009. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 373: 48–57. doi:10.1016/S0140-6736(08)61697-9.PubMedCrossRef Granich, R.M., C.F. Gilks, C. Dye, K.M. DeCock, and B.G. Williams. 2009. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 373: 48–57. doi:10.​1016/​S0140-6736(08)61697-9.PubMedCrossRef
go back to reference Marks, G., N. Crepaz, J.W. Senterfitt, and R.S. Janssen. 2005. Meta-analysis of high-risk sexual behaviour in persons aware and unaware they are infected with HIV in the United States. Implications for HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes 39: 446–453. doi:10.1097/01.qai.0000151079.33935.79.PubMedCrossRef Marks, G., N. Crepaz, J.W. Senterfitt, and R.S. Janssen. 2005. Meta-analysis of high-risk sexual behaviour in persons aware and unaware they are infected with HIV in the United States. Implications for HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes 39: 446–453. doi:10.​1097/​01.​qai.​0000151079.​33935.​79.PubMedCrossRef
go back to reference Rennie, S., and F. Behets. 2006. Desperately seeking targets: The ethics of routine HIV testing in low-income countries. Bulletin of the World Health Organization 84: 52–57. doi:10.2471/BLT.05.025536.PubMed Rennie, S., and F. Behets. 2006. Desperately seeking targets: The ethics of routine HIV testing in low-income countries. Bulletin of the World Health Organization 84: 52–57. doi:10.​2471/​BLT.​05.​025536.PubMed
go back to reference Weiser, S.D., M. Heisler, K. Leiter, F. Percy-de Korte, F. Tlou, S. DeMonner, et al. 2006. Routine HIV testing in Botswana: A population-based study on attitudes, practices, and human rights concerns. PLoS Medicine 3(7): 1013–1022. e261.CrossRef Weiser, S.D., M. Heisler, K. Leiter, F. Percy-de Korte, F. Tlou, S. DeMonner, et al. 2006. Routine HIV testing in Botswana: A population-based study on attitudes, practices, and human rights concerns. PLoS Medicine 3(7): 1013–1022. e261.CrossRef
Metadata
Title
Increasing Knowledge of HIV Infection Status through Opt-Out Testing
Opt-Out HIV Testing
Author
Harold W. Jaffe
Publication date
01-06-2009
Publisher
Springer Netherlands
Published in
Journal of Bioethical Inquiry / Issue 2/2009
Print ISSN: 1176-7529
Electronic ISSN: 1872-4353
DOI
https://doi.org/10.1007/s11673-009-9147-4

Other articles of this Issue 2/2009

Journal of Bioethical Inquiry 2/2009 Go to the issue

OriginalPaper

Recent Developments